ClinicalTrials.gov record
The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study
COMPLETED · NCT00599222
Trial record
NCT IDNCT00599222
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE3
Enrollment
100
Conditions
Neovascular Age-related Macular Degeneration
Interventions
ranibizumab, TTT, Sham TTT
Locations
St Eriks Eye Hospital, Stockholm, Sweden
Indexed topics
Last update
2011-11-21